Modeling Diabetic Cardiomyopathy

Modeling Diabetic Cardiomyopathy

Diabetic cardiomyopathy is a complication of type 2 diabetes that results from lifestyle and genetic conditions. CDI’s cardiomyocytes have been used to develop environmental and patient-specific in vitro models that recapitulate this complex metabolic condition. These models are employed in a phenotypic screening assay resulting in the identification of candidate protective molecules.